[Potential harms associated with 4-aminoquinoline treatment].

Clicks: 358
ID: 106146
2020
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #4 of 7 articles by views in lakartidningen

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Hydroxychloroquine and chloroquine are currently being evaluated as treatment against COVID-19. These drugs are associated with some potential harms, including QTc-interval prolongation, hypoglycaemia, severe skin reactions and psychiatric effects. Use of hydroxychloroquine or chloroquine should be reserved to current indications or clinical trials, as recommended by several governmental medical products agencies.
Reference Key
svensson2020potentiallakartidningen Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Svensson, Markus;
Journal lakartidningen
Year 2020
DOI
F3UD
URL
Keywords
cytokine covid-19 sars-cov-2 il-2r/lymphocyte ratio clinical progression

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.